OBJECTIVE: To study predictors of non-stabilization (i.e., not bimodally stabilized for randomization or not randomized due to premature discontinuation) during open-label treatment with lithium and divalproex in patients with rapid-cycling bipolar disorder (RCBD) with or without comorbid recent substance use disorders (SUDs). METHOD: Data from the open-label phase of two maintenance studies were used. The reasons for non-stabilization were compared between patients with a recent SUD and those without. Predictors for non-stabilization were explored with logistic regression analyses. RESULTS: Of 149 patients with recent SUD and 254 without recent SUD enrolled into the open-label acute stabilization phase, 21% and 24% were stabilized and randomized, respectively. Compared to those without recent SUD, patients with recent SUD were more likely to discontinue the study due to non-adherence to the protocol, 53% versus 37% (OR = 1.92) or refractory mania/hypomania, 15% versus 9% (OR = 1.87), but less likely due to refractory depression 16% versus 25% (OR = 0.58) or adverse events, 10% versus19% (OR = 0.44). A history of recent SUDs, early life verbal abuse, female gender, and late onset of first depressive episode were associated with increased risk for non-stabilization with ORs of 1.85, 1.74, 1.10, and 1.04, respectively. CONCLUSIONS: During open treatment with lithium and divalproex in patients with RCBD, a recent SUD, a lifetime history of verbal abuse, female gender, and late onset of first depression independently predicted nonstabilization. The non-stabilization for patients with SUD was related to non-adherence and refractory mania/hypomania.
RCT Entities:
OBJECTIVE: To study predictors of non-stabilization (i.e., not bimodally stabilized for randomization or not randomized due to premature discontinuation) during open-label treatment with lithium and divalproex in patients with rapid-cycling bipolar disorder (RCBD) with or without comorbid recent substance use disorders (SUDs). METHOD: Data from the open-label phase of two maintenance studies were used. The reasons for non-stabilization were compared between patients with a recent SUD and those without. Predictors for non-stabilization were explored with logistic regression analyses. RESULTS: Of 149 patients with recent SUD and 254 without recent SUD enrolled into the open-label acute stabilization phase, 21% and 24% were stabilized and randomized, respectively. Compared to those without recent SUD, patients with recent SUD were more likely to discontinue the study due to non-adherence to the protocol, 53% versus 37% (OR = 1.92) or refractory mania/hypomania, 15% versus 9% (OR = 1.87), but less likely due to refractory depression 16% versus 25% (OR = 0.58) or adverse events, 10% versus19% (OR = 0.44). A history of recent SUDs, early life verbal abuse, female gender, and late onset of first depressive episode were associated with increased risk for non-stabilization with ORs of 1.85, 1.74, 1.10, and 1.04, respectively. CONCLUSIONS: During open treatment with lithium and divalproex in patients with RCBD, a recent SUD, a lifetime history of verbal abuse, female gender, and late onset of first depression independently predicted nonstabilization. The non-stabilization for patients with SUD was related to non-adherence and refractory mania/hypomania.
Authors: Theodore V Cooper; Margaret W DeBon; Michelle Stockton; Robert C Klesges; Timothy A Steenbergh; Deborah Sherrill-Mittleman; Lyndy C Jennings; Karen C Johnson Journal: Addict Behav Date: 2004-11 Impact factor: 3.913
Authors: Alan C Swann; David G Daniel; Lisa D Kochan; Patricia J Wozniak; Joseph R Calabrese Journal: J Clin Psychiatry Date: 2004-06 Impact factor: 4.384
Authors: Martha Sajatovic; Rosalinda V Ignacio; Jane A West; Kristin A Cassidy; Roknedin Safavi; Amy M Kilbourne; Frederic C Blow Journal: Compr Psychiatry Date: 2008-08-23 Impact factor: 3.735
Authors: Keming Gao; Bryan K Tolliver; David E Kemp; Marcia L Verduin; Stephen J Ganocy; Sarah Bilali; Kathleen T Brady; Seong S Shim; Robert L Findling; Joseph R Calabrese Journal: J Affect Disord Date: 2008-01-29 Impact factor: 4.839
Authors: Robert L Findling; Nora K McNamara; Barbara L Gracious; Eric A Youngstrom; Robert J Stansbrey; Michael D Reed; Christine A Demeter; Lisa A Branicky; Kathryn E Fisher; Joseph R Calabrese Journal: J Am Acad Child Adolesc Psychiatry Date: 2003-08 Impact factor: 8.829
Authors: Zuowei Wang; Keming Gao; David E Kemp; Philip K Chan; Mary Beth Serrano; Carla Conroy; Yiru Fang; Stephen J Ganocy; Robert L Findling; Joseph R Calabrese Journal: Psychopharmacol Bull Date: 2010